These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31162912)

  • 1. [Role of drinking and dietary factors in effective dissolution therapy and recurrence prevention of uric acid kidney stones].
    Saenko VS; Pesegov SV; Frolova EA
    Urologiia; 2019 Jun; (2):113-118. PubMed ID: 31162912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?
    Siener R
    Urolithiasis; 2016 Feb; 44(1):51-6. PubMed ID: 26614113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and prevention of uric acid stones].
    Ferrari P; Bonny O
    Ther Umsch; 2004 Sep; 61(9):571-4. PubMed ID: 15493118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of the diuretic efficacy and tolerability of therapy with Rocchetta mineral water in patients with recurrent calcium kidney stones].
    Trinchieri A; Boccafoschi C; Chisena S; De Angelis M; Seveso M
    Arch Ital Urol Androl; 1999 Apr; 71(2):121-4. PubMed ID: 10408129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.
    Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA
    J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary alkalization for the treatment of uric acid nephrolithiasis.
    Cicerello E; Merlo F; Maccatrozzo L
    Arch Ital Urol Androl; 2010 Sep; 82(3):145-8. PubMed ID: 21121431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid nephrolithiasis: current concepts and controversies.
    Shekarriz B; Stoller ML
    J Urol; 2002 Oct; 168(4 Pt 1):1307-14. PubMed ID: 12352383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of kidney stones.
    Pak CY
    Expert Opin Pharmacother; 2008 Jun; 9(9):1509-18. PubMed ID: 18518781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate.
    Trinchieri A; Esposito N; Castelnuovo C
    Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of theobromine on dissolution of uric acid kidney stones.
    Julià F; Costa-Bauza A; Berga F; Grases F
    World J Urol; 2022 Aug; 40(8):2105-2111. PubMed ID: 35689678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary therapy in idiopathic nephrolithiasis.
    Borghi L; Meschi T; Maggiore U; Prati B
    Nutr Rev; 2006 Jul; 64(7 Pt 1):301-12. PubMed ID: 16910218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of the recurrence of urinary lithiasis: mineral waters with high or low calcium content?].
    Sommariva M; Rigatti P; Viola MR
    Minerva Med; 1987 Dec; 78(24):1823-9. PubMed ID: 3431728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mineral water containing calcium and magnesium on calcium oxalate urolithiasis risk factors.
    Rodgers AL
    Urol Int; 1997; 58(2):93-9. PubMed ID: 9096270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrate therapy for calcium phosphate stones.
    Rimer JD; Sakhaee K; Maalouf NM
    Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):130-139. PubMed ID: 30531474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetazolamide is an effective adjunct for urinary alkalization in patients with uric acid and cystine stone formation recalcitrant to potassium citrate.
    Sterrett SP; Penniston KL; Wolf JS; Nakada SY
    Urology; 2008 Aug; 72(2):278-81. PubMed ID: 18533229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.